C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A01K 67/027 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2528143
The present invention relates to the identification of a novel nucleotide polymorphism in the inhibin beta-A (INHBA) gene and the exploitation of this nucleotide polymorphism in the diagnosis of susceptibility to bone damage, particularly fracture. Also provided are transgenic non-human animals comprising the polynucleotides of the present invention and methods and kits for diagnosing and/or determining susceptibility to bone damage.
La présente invention concerne l'identification d'un nouveau polymorphisme nucléotidique dans le gène de la bêta inhibine A (INHBA) et l'exploitation dudit polymorphisme nucléotidique dans le diagnostic d'une susceptibilité à des lésions osseuses, notamment à la fracture. L'invention concerne également des animaux transgéniques non humains comprenant les polynucléotides selon la présente invention ainsi que des méthodes et des matériels permettant de diagnostiquer et/ou de déterminer une susceptibilité à des lésions osseuses.
Bennett Simon Thomas
Edwards Mark
Borden Ladner Gervais Llp
Century Technology Inc.
Oxagen Limited
LandOfFree
Method of diagnosing a genetic susceptibility for bone damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing a genetic susceptibility for bone damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing a genetic susceptibility for bone damage will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1971694